The UK has agreed a deal with the USA for a 0% tariff on pharmaceuticals in return for a 25% increase to the threshold at which the National Health Service (NHS) deems medicines to be cost-effective.
[News] UK–US drug pricing deal to cost NHS £3 billion as NICE increases new medicines threshold
The Lancet Oncology | | Emma Wilkinson
Topics: cervical-cancer